Friday, July 25, 2008 - 12:45PM EST

Clinical Trials

1. Adjunctive topiramate treatment in refractory obese bipolar patients: a descriptive open label study.

Author
Gabriel A;
Institution
University of Calgary, Calgary, Alberta, Canada. gabriel@ucalgary.ca
Journal
Eat Weight Disord. 2007 Mar;12(1):48-53.
Abstract URL
Click here to view abstract

2. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials.

Author
Calabrese JR; Huffman RF; White RL; Edwards S; Thompson TR; Ascher JA; Monaghan ET; Leadbetter RA;
Institution
Case Western Reserve University School of Medicine/University Hospitals of Cleveland, Cleveland, OH, USA. joseph.calabrese@uhhospitals.org
Journal
Bipolar Disord. 2008 Mar;10(2):323-33.
Abstract URL
Click here to view abstract

3. Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study.

Author
Maina G; Albert U; Rosso G; Bogetto F;
Institution
Department of Neurosciences, Mood and Anxiety Disorders Unit, University of Turin, Turin, Italy. giuseppemaina@hotmail.com
Journal
J Clin Psychiatry. 2008 Apr;69(4):609-16.
Abstract URL
Click here to view abstract

4. Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder.

Author
Suppes T; Eudicone J; McQuade R; Pikalov A 3rd; Carlson B;
Institution
Bipolar Disorder Research Program, UT Southwestern Medical Center, Dallas, Texas 75390-9121, USA. trisha.suppes@utsouthwestern.edu
Journal
J Affect Disord. 2008 Apr;107(1-3):145-54. Epub 2007 Sep 27.
Abstract URL
Click here to view abstract

5. Mindfulness-based Cognitive Therapy (MBCT) in bipolar disorder: preliminary evaluation of immediate effects on between-episode functioning.

Author
Williams JM; Alatiq Y; Crane C; Barnhofer T; Fennell MJ; Duggan DS; Hepburn S; Goodwin GM;
Institution
University of Oxford, Department of Psychiatry, Warneford Hospital, Warneford Lane, Headington, Oxford, OX3 7JX, UK. mark.williams@psych.ox.ac.uk
Journal
J Affect Disord. 2008 Apr;107(1-3):275-9. Epub 2007 Sep 19.
Abstract URL
Click here to view abstract

6. The effects of pentazocine, a kappa agonist, in patients with mania.

Author
Cohen BM; Murphy B;
Institution
McLean Hospital, Belmont, MA 02478, USA. cohenb@mclean.harvard.edu
Journal
Int J Neuropsychopharmacol. 2008 Mar;11(2):243-7. Epub 2007 Sep 26.
Abstract URL
Click here to view abstract

7. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.

Author
Vieta E; Calabrese JR; Goikolea JM; Raines S; Macfadden W;
Institution
Bipolar Disorders Programme, Clinical Institute of Neuroscience, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain. evieta@clinic.ub.es
Journal
Bipolar Disord. 2007 Jun;9(4):413-25.
Abstract URL
Click here to view abstract

8. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.

Author
Yatham LN; Vieta E; Young AH; Moller HJ; Paulsson B; Vagero M;
Institution
Division of Mood Disorders, University of British Columbia, UBC Hospital, Vancouver, British Columbia, Canada. yatham@interchange.ubc.ca
Journal
Int Clin Psychopharmacol. 2007 Jul;22(4):212-20.
Abstract URL
Click here to view abstract

9. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.

Author
Nery FG; Monkul ES; Hatch JP; Fonseca M; Zunta-Soares GB; Frey BN; Bowden CL; Soares JC; Nery FG; Monkul ES; Hatch JP; Fonseca M; Zunta-Soares GB; Frey BN; Bowden CL; Soares JC;
Institution
Department of Psychiatry, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Journal
Hum Psychopharmacol. 2008 Mar;23(2):87-94.
Abstract URL
Click here to view abstract

10. Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study.

Author
Li H; Ma C; Wang G; Zhu X; Peng M; Gu N;
Institution
Shanghai Mental Health Center, Shanghai, China.
Journal
Curr Med Res Opin. 2008 Jan;24(1):1-10.
Abstract URL
Click here to view abstract
Pages: 1 2 3